Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Quadruple Therapy Duration and Probiotics for H. pylori
NCT04527055Phase 4Enrolling by invitation
- Sponsor
- National Cheng Kung University Hospital
- Start
- May 2020
- Primary completion
- Jul 2028
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subcitrate, esomeprazole, metronidazole, tetracycline in Helicobacter pylori infection, sponsored by National Cheng Kung University Hospital. Started May 2020; status: enrolling by invitation.
02
Drugs
bismuth subcitrateesomeprazolemetronidazoletetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04527055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04527055.